Nephrotic SyndromeNCT03001934
Super Chinese Nephrotic Syndrome Registration System (SUCCESS)
An observational study of Nephrotic Syndrome, run by Sun Yat-sen University at 1 site in China.
Trial summary
The investigators are registering all nephrotic syndrome (NS) patients regardless of the primary causes and developing a NS database in China. Patients will be followed-up and both baseline and follow-up information will be recorded in the registration system. Read more about this study
- Who is it for?
- Ages 14 years and older
- Conditions the study is for
- Nephrotic Syndrome
- How many people
- 5,000 participants
- Where
- 1 siteChina
- Study dates
- Apr 2016to Dec 2029
- How long will I take part?
- 10 Years
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Nephrotic syndrome patients
Who may be able to join
- Nephrotic syndrome patients regardless of the primary causes
Who cannot join
- No
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Xueqing Yu, M.D. & Ph.D contact
Naya Huang, M.D. & Ph.D contact
China1 site, 1 recruiting
- Recruiting
The 1st Affiliated Hospital, Sun Yet-sen University
Guangzhou, Guangdong, 510080
Xueqing Yu, M.D. & Ph.D., yuxq@mail.sysu.edu.cn
Xueqing Yu, MD
About this study
The investigators are registering all nephrotic syndrome (NS) patients regardless of the primary causes and developing a NS database in China. Patients will be followed-up and both baseline and follow-up information will be recorded in the registration system. The treatment response, longitudinal changes of renal function, renal survival, patient survival, infection events and acute kidney injury etc, will be analyzed using the NS database.
Read the detailed description
The investigators are registering all NS patients regardless of the primary causes in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education), clinical characteristics (including systolic blood pressure, diastolic blood pressure, primary cause of NS, and lab measurements of serum, urine), pathological characteristics, treatment and treatment response, complications and outcomes. Patients will be followed up, the demographic, clinical characteristics, treatment, lab tests of blood and urine and complications of patients will be collected and recorded at each visit. The investigators also record the outcome at each visit, such as treatment response, longitudinal changes of renal function, hospitalization, occurrence of infection or cardiovascular events etc. The outcomes will be analyzed using the NS database.
- Conditions
- Nephrotic Syndrome
- Being tested
- No intervention
- Keywords
- Nephrotic syndrome, Treatment response, Renal function
- Medical subject headings
- Nephrotic Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No interventionOther
Registration of all NS patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals which have signed the contract in China.
| Study group | Role | What they receive |
|---|---|---|
| Nephrotic syndrome patients | Patients diagnosis as nephrotic syndrome (NS) Receives: Other: No intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
The patient survival in NS patients
Measured: 10 years
Secondary outcomes (4)
Renal survival in NS patients
Renal survival including end stage renal disease, dialysis, renal transplantation
Measured: 10 years
Longitudinal changes of renal function of NS patients
Measured: 10 years
Treatment response of NS patients
Measured: 10 years
Infection rate of NS patients
Measured: 10 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Dec 2016 (estimated)
- Study startApr 2016
- Primary completionDec 2029 (estimated)
- Study completionDec 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Nephrotic SyndromeStudies of the same condition, open and under way.
- More trials run by Sun Yat-sen UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 5,000 participants (estimated)
- Target duration
- 10 Years
Sponsor and investigators
- Lead sponsor
- Sun Yat-sen University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Xue Qing Yu, Sun Yat-sen University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03001934
- Sponsor's protocol ID
- SUCCESS
- Status last verified
- Sep 2026
- First submitted
- 21 Dec 2016
- Last updated
- 15 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- Yes